Acta Med. 2004, 47: 13-18

Anticholinergic Drugs – Functional Antidotes for the Treatment of Tabun Intoxication

Gabriela Krejčová, Jiří Kassa

Purkyně Military Medical Academy in Hradec Králové, Department of Toxicology, Hradec Králové, Czech Republic

Received October 1, 2003
Accepted December 1, 2003


1. Bajgar J, Fusek J, Vachek J. Treatment and prophylaxis against nerve agent poisoning. ASA Newslett. 1994; 94:10–7.
2. Clement JG, Shiloff JD, Gennings C. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning in mice. Arch Toxicol 1987; 61:70–5. <>
3. Frantík E, Hornychová M. Clustering of neurobehavioral measures of toxicity. Homeostasis 1995; 36:19–25.
4. Jokanovic M, Maksimovic M, Kilibarda V, Jovanovic D, Savic D. Oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates. Toxicol Lett 1996; 85:35–9. <>
5. Kassa J, Vachek J. A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice. Toxicology 2002; 177:179–85. <>
6. Krejcova G, Kassa J. Neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in tabun-poisoned rats. Toxicology 2003; 185:129–39. <>
7. Luo Ch, Leader H, Radic Z et al. Two possible orientation of the HI-6 molecule in the reactivation of organophosphate-inhibited acetylcholinesterase. Biochem Pharmacol 2003; 66(3):387–92. <>
8. McLeod CG, Singer W, Harrington DG. Acute neuropathology in soman poisoned rats. Fundam Appl Toxicol 1984; 5:53–8.
9. Moser VC, Becking GC, Cuomo V et al. The IPCS collaborative study on neurobehavioral screening methods: III. Results of proficiency studies. Neurotoxicology 1997; 18:939–46.
10. Moser VC, Becking GC, Cuomo V et al. The IPCS collaborative study on neurobehavioral screening methods: V. Results of chemical testing. Neurotoxicology 1997; 18:969–1056.
11. Moser VC, Tilson H, McPhail RC et al. The IPCS collaborative study on neurobehavioral screening methods: II. Protocol design and testing procedures. Neurotoxicology 1997; 18:929–38.
12. Petras JM. Soman neurotoxicity. Fundam Appl Toxicol 1983; 1:73–83.
13. Puu G, Artursson, E, Bucht G. Reactivation of nerve agent inhibited acetylcholinesterases by HI-6 and obidoxime. Biochem Pharmacol 1986; 35:1505–10. <>
14. Solberg Y, Belkin M. The role of excitotoxicity in organophosphorus nerve agents central poisoning. Trends Pharmacol Sci 1997; 18:183–5. <>
15. Taylor P. Anticholinesterase agents. In: Hardman JG, Limbird LE, editors. The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw Hill, 1996: p.161–76.
16. Tonduli LS, Testylier G, Masqueliez C, Lallement G, Monmaur P. Effects of huperzine used as pre-treatment against soman-induced seizures. Neurotoxicology 2001; 22(1):29–37. <>
17. Vasilesceu C, Floresceu C. Clinical and electrophysiological study of neuropathy after organophosphorus compound poisoning. Arch Toxicol 1980; 43:305–15. <>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal